Attached files
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. Sec.1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of MabVax Therapeutics Holdings,
Inc. (the Company) on Form 10-K for the year ended
December 31, 2016 as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, J. David Hansen,
President and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to my
knowledge:
|
1)
|
The Report fully complies with the requirements of
Section 13(a) or 15 (d) of the Securities Exchange Act of
1934; and
|
|
2)
|
The information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
March 1, 2017
/s/
J. David Hansen
|
J. David Hansen
|
President and Chief Executive Officer
|
(Principal Executive Officer)
|
A signed original of this written statement required by
Section 906 of the Sarbanes-Oxley Act of 2002 has been
provided to MabVax Therapeutics Holdings, Inc. and will be
furnished to the Securities and Exchange Commission or its staff
upon request.